0
Correspondence |

Clinical Importance of Effect Size in Randomized Controlled Trials

Tetsuji Fujita, MD
Arch Surg. 2010;145(4):400-401. doi:10.1001/archsurg.2010.47.
Text Size: A A A
Published online

Extract

I read with interest the editorial1 in the August 2009 issue of Archives that tells us the need for effect size estimation in randomized controlled trials (RCTs). In addition to determining primary end points, estimating sample size, and identifying α and β levels that indicate the probability of type I or II error, prespecifying effect size is required for designing RCTs.2 As discussed in the article, Cohen d, defined as standardized mean difference and scaled and classified as small (d = 0.2), medium (d = 0.5), or large (d = 0.8), is commonly used as an effect size for continuous data following a normal distribution. However, an effect size of 0.2 could be considered large in some contexts, such as vaccination to prevent polio in the general pediatric population, and an effect size of 0.8 small in others.3 Consequently, we are faced with the crucial question of how large an effect size has to be to be clinically important. Although the article does not solve this problem, it is suggested that clinical significance of effect size is dependent on factors such as the severity of the condition and the convenience and cost of the intervention.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

April 1, 2010
Edward H. Livingston, MD; Alan C. Elliot, MS; Linda S. Hynan, PhD; Jing Cao, PhD
Arch Surg. 2010;145(4):401. doi:10.1001/archsurg.2010.48.
CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
Jobs
brightcove.createExperiences();